Infertility Treatment Market was valued at USD 1.76 Billion in 2023, and it is expected to reach USD 3.03 Billion by 2030, exhibiting a CAGR of 8.06% during the forecast period (2024-2030).Infertility Treatment Market Overview
The market for infertility treatments includes a wide range of medical interventions, assisted reproductive technologies (ART), and supportive therapies designed to help individuals and couples achieve successful pregnancies. The major driving factors for global infertility treatment market include declining global fertility rate, rising number of fertility conventions worldwide, technological advancements, and accelerating public-private investments, resources, grants, and increasing adoption of surrogacy by single parents and same- sex couples. The future of the market is marked by a trajectory towards personalized, accessible, and comprehensive reproductive care, emphasizing not only treatment efficacy but also the overall well-being of individuals and couples pursuing the dream of parenthood.To know about the Research Methodology:-Request Free Sample Report Infertility Treatment Market Report Scope and Research Methodology The objective of the report is to present a comprehensive analysis of the global Infertility Treatment Market to the stakeholders in the devices. The past and current status of the Surgery with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the Surgery with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTLE analysis with the potential impact of micro-economic factors of the Infertility Treatment market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the Surgery to the decision-makers. The reports also help in understanding the Market dynamic, structure by analysing the market segments and projecting the Infertility Treatment Market size. Clear representation of competitive analysis of key players by price, financial position, Surgery portfolio, growth strategies, and End-Industrial presence in the Infertility Treatment Market make the report investor’s guide.
Infertility Treatment Market Dynamics
Increasing Investments in the Healthcare Infrastructure driving the Global Infertility Treatment Market The anticipated rise in federal government funding is poised to propel the market growth rate. Furthermore, the healthcare industry's expansion, driven by both public and private entities, particularly in developing economies, presents lucrative opportunities for market growth. The assurance of high returns on investments from research activities is also a favorable factor for the market. Moreover, the market stands to benefit from an upswing in the occurrences of lifestyle diseases, genetic abnormalities, stress, obesity, prostate cancer, varicocele, and other health conditions. An increase in personal disposable income levels, a growing number of fertility clinics globally, augmented investments in advanced medical products and devices, and the emergence of promising markets like China, India, Brazil, and Mexico collectively contribute positively to the Infertility Treatment market's growth trajectory. Technological Advancements creating Opportunities for the Global Infertility Treatment Market Over the past few years, there has been notable progress in the field of reproductive medicine, leading to substantial advancements in the effectiveness and viability of In Vitro Fertilization (IVF). This evolution has transformed IVF into a progressively more feasible option for couples facing challenges with infertility, owing to continuous research and innovative developments in the field. Recent breakthroughs in IVF technology are revolutionizing the realm of fertility treatment. Innovations ranging from genetic screening to time-lapse embryo imaging, artificial intelligence, and enhanced culture media are providing a ray of hope for couples facing infertility challenges. With ongoing advancements in research and technology, the prospects of success in IVF are consistently on the rise, bringing the aspiration of parenthood within reach for an increasing number of individuals and families across the world. These are expected to drive the global Infertility Treatment Market growth during the forecast period.High Cost Associated with the Treatments Restraining the Infertility Treatment Market Growth Infertility treatments, especially advanced procedures such as In Vitro Fertilization (IVF) and other assisted reproductive technologies (ART), often involve substantial expenses. The financial burden is a source of stress and anxiety for individuals or couples already grappling with the emotional challenges of infertility. This strain leads some to forego or delay seeking treatment due to financial constraints. Infertility treatments requires multiple cycles to achieve success, amplifying the overall cost. Each cycle of treatment includes expenses related to diagnostic tests, medications, medical procedures, and laboratory services. The cumulative financial commitment over multiple cycles are overwhelming for individuals or couples, deterring them from pursuing additional attempts.
Advancement Explanation Preimplantation Genetic Testing (PGT) Preimplantation Genetic Testing (PGT) enables the screening of embryos to detect genetic abnormalities prior to implantation, thereby elevating the likelihood of a successful pregnancy through the selection of healthy embryos. Time-lapse Embryo Imaging Employing time-lapse technology for ongoing monitoring of embryo development enables enhanced selection based on growth patterns and developmental milestones, thereby contributing to improved success rates in IVF. Artificial Intelligence (AI) & Machine Learning Utilizing AI and machine learning, patient data and embryonic development are analyzed to offer tailored treatment recommendations, enhancing the outcomes of IVF. Ovarian Tissue Cryopreservation This technology facilitates the cryopreservation of ovarian tissue containing viable eggs, providing an option for women undergoing cancer treatment or other medical procedures that may impact fertility. Improved Culture Media The utilization of advanced culture media formulations establishes an optimal laboratory environment for embryo development, resulting in improved embryo quality and higher rates of success in IVF. Single Embryo Transfer (SET) By transferring a meticulously selected single embryo, Single Embryo Transfer (SET) aims to decrease the likelihood of multiple pregnancies. This approach ensures elevated success rates while simultaneously mitigating potential complications. Egg Freezing Techniques The success rates of egg freezing have been enhanced with the adoption of vitrification, a swift freezing technique, providing women with expanded choices for preserving their fertility. Infertility Treatment Market Regional Insights
Asia Pacific Infertility Treatment Market held the largest share in the global market in 2023. This is attributed to the surge in government initiatives aimed at fostering awareness, a notable uptick in medical tourism, increasing research endeavors, a rise in lifestyle-related diseases, a growing demand for smoking products, and an escalating need for high-quality healthcare services. Japan, renowned for having one of the world's most aged populations, has witnessed a prolonged decline in its birth rate spanning several decades. Contributing factors to this decline include the increasing cost of living, gender inequality, and a growing hesitancy towards marriage. In recent times, the Japanese government has undertaken substantial initiatives to extend national coverage for fertility treatments. This involves a comprehensive strategy of subsidizing 70% of the expenses associated with in vitro fertilization (IVF) for up to six cycles. Notably, certain local governments, particularly in rural regions, have taken additional measures by agreeing to cover the remaining 30% of the treatment costs. This collective effort aims to enhance accessibility to fertility treatments for all segments of the population, irrespective of financial constraints. In 2022, India Infertility Treatment Market, which had previously lacked regulations governing fertility care processes, underwent a significant transformation with the implementation of two groundbreaking laws. The first of these, the Assisted Reproductive Technology (Regulation) Act, 2021, introduces regulations determining eligibility for assisted reproductive technology (ART) treatment, mandates the establishment of a registry for ART clinics, and oversees the procedures involved in ART treatments. The second law, the Surrogacy (Regulation) Act, 2021, specifically addresses the regulation of gestational surrogacy (GS) journeys. A noteworthy change introduced by these laws is the prohibition of commercial GS journeys. These regulatory measures were prompted, in part, by mounting concerns surrounding infertility rates and the substantial proliferation of ART clinics, leading to India's emergence as one of the world's fastest-growing hubs for such facilities.Infertility Treatment Market Segment Analysis
By Procedure, the medication segment estimated for a largest Infertility Treatment market share share in 2030. The medication segment is the largest contributor due to a wide range and operation. The adding blessing of fertility services and artistic shifts has led to high demand for medicine and treatments. The mindfulness of sterility treatment has increased over time, thereby reducing the hesitancy of people to conclude for drug. The high acceptance rate is because of the enhancement in success rate and advanced ways to cure sterility. ART procedures include different procedures like artificial copulation, in- vitro fertilization IVF, surrogacy, and others. The favourable fiscal support for ART procedures in both developed and emerging countries is another factor contributing to the growth. The surgical interventions segment is anticipated to witness gradational growth by 2030. Surgical interventions are considered as the alternate line of care after drug. This segment is likely to see an incremental growth of around$ 200 million during the forecasting period.By End-User, Fertility clinics dominate the Infertility Treatment market due to the high success rate of fertility services and IVF clinics. The number of fertility centers is expanding across the globe. These conventions enthral the largest share in the gravidity treatment request. Fertility centers offer different services, similar as IVF programs, egg donation, ICSI, IMSI, and other services. The member is projected to hold the highest share during the forecast period. This is due to the constant rise in conventions and adding connection of clinics with fertile advisers and experts. Hospitals are a significantly fast- growing member. They give traditional medical care, similar as fertility drugs, medicines, conventions, and surgeries. They also grease procedures similar as IVF and ART, which are likely to have significant demand during the cast period. Gynaecologists and urologist conventions offer high- quality women’s healthcare services, including labour care, and define drug for fertility treatment. They're primary healthcare centers performing primary fertility evaluations among end- users. Hence, this member is anticipated to grow at a steady growth during the forecasting period.
Infertility Treatment Market Scope: Inquire before buying
Infertility Treatment Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 1.76 Bn. Forecast Period 2024 to 2030 CAGR: 4.4% Market Size in 2030: US $ 3.03 Bn. Segments Covered: by Procedure Assisted Reproductive Technology In-vitro Fertilization Intracytoplasmic Sperm Injection Gamete Donation Surrogacy Artificial Insemination Intrauterine Insemination Drug Therapy ART Procedure Surgical Intervention Fertility Surgeries Others by Patient Male Treatment Female Treatment by End-User Fertility Centers Hospitals & Surgical Clinics Cryobanks Research Institutes Infertility Treatment Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Infertility Treatment Key Players
1. CCRM 2. Ferring Pharmaceutical 3. Merck & Co 4. Monash IVF Group 5. The Cooper Company 6. Thermo Fisher 7. United Healthcare Group 8. Surelife Pte Ltd. 9. Biogenics Inc. 10. Cook Group Incorporated 11. Esco Micro Pte. Ltd. 12. Genea Limited 13. Hamilton Throne Ltd. 14. Ihmedical A/S 15. Invo Bioscience 16. Irvine Scientific 17. Ivftech APS 18. Kitazato 19. Labotect GmbH 20. Lifeglobal Group LLC 21. Medgyn Products Inc. 22. Microtech Ivf S.R.O. 23. Nikon Instruments Inc. 24. Ri.Mos 25. Rinovum Women's Health Company 26. Rocket Medical PLC 27. Somatex Medical Technologies GmbH 28. The Baker Company Inc. 29. The Cooper Companies Inc. 30. Thermo Fisher Scientific Inc. 31. Vitrolife AB 32. Zander Scientific Inc. Frequently Asked Questions: 1] What segments are covered in the Global Infertility Treatment Market report? Ans. The segments covered in the Infertility Treatment Market report are based on Procedure, Patient and End-User. 2] Which region is expected to hold the largest share in the Global Infertility Treatment Market? Ans. The Asia Pacific region is expected to hold the largest share in the Infertility Treatment Market. 3] What is the expected Global Infertility Treatment Market size by 2030? Ans. The Infertility Treatment Market size by 2030 is expected to reach USD 3.03 Bn. 4] What is the forecast period for the Global Infertility Treatment Market? Ans. The forecast period for the Infertility Treatment Market is 2024-2030. 5] What was the market size of the Global Infertility Treatment Market in 2023? Ans. The Infertility Treatment market size in 2023 was valued at USD 1.76 Bn.
1. Infertility Treatment Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Infertility Treatment Market: Dynamics 2.1. Infertility Treatment Market Trends by Region 2.1.1. North America Infertility Treatment Market Trends 2.1.2. Europe Infertility Treatment Market Trends 2.1.3. Asia Pacific Infertility Treatment Market Trends 2.1.4. Middle East and Africa Infertility Treatment Market Trends 2.1.5. South America Infertility Treatment Market Trends 2.2. Infertility Treatment Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Infertility Treatment Market Drivers 2.2.1.2. North America Infertility Treatment Market Restraints 2.2.1.3. North America Infertility Treatment Market Opportunities 2.2.1.4. North America Infertility Treatment Market Challenges 2.2.2. Europe 2.2.2.1. Europe Infertility Treatment Market Drivers 2.2.2.2. Europe Infertility Treatment Market Restraints 2.2.2.3. Europe Infertility Treatment Market Opportunities 2.2.2.4. Europe Infertility Treatment Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Infertility Treatment Market Drivers 2.2.3.2. Asia Pacific Infertility Treatment Market Restraints 2.2.3.3. Asia Pacific Infertility Treatment Market Opportunities 2.2.3.4. Asia Pacific Infertility Treatment Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Infertility Treatment Market Drivers 2.2.4.2. Middle East and Africa Infertility Treatment Market Restraints 2.2.4.3. Middle East and Africa Infertility Treatment Market Opportunities 2.2.4.4. Middle East and Africa Infertility Treatment Market Challenges 2.2.5. South America 2.2.5.1. South America Infertility Treatment Market Drivers 2.2.5.2. South America Infertility Treatment Market Restraints 2.2.5.3. South America Infertility Treatment Market Opportunities 2.2.5.4. South America Infertility Treatment Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Infertility Treatment Industry 2.8. Analysis of Government Schemes and Initiatives For Infertility Treatment Industry 2.9. Infertility Treatment Market Trade Analysis 2.10. The Global Pandemic Impact on Infertility Treatment Market 3. Infertility Treatment Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 3.1.1. Assisted Reproductive Technology 3.1.2. In-vitro Fertilization 3.1.3. Intracytoplasmic Sperm Injection 3.1.4. Gamete Donation 3.1.5. Surrogacy 3.1.6. Artificial Insemination 3.1.7. Intrauterine Insemination 3.1.8. Drug Therapy 3.1.9. ART Procedure 3.1.10. Surgical Intervention 3.1.11. Fertility Surgeries 3.1.12. Others 3.2. Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 3.2.1. Male Treatment 3.2.2. Female Treatment 3.3. Infertility Treatment Market Size and Forecast, by End User (2023-2030) 3.3.1. Fertility Centers 3.3.2. Hospitals & Surgical Clinics 3.3.3. Cryobanks 3.3.4. Research Institutes 3.4. Infertility Treatment Market Size and Forecast, by Region (2023-2030) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Infertility Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 4.1.1. Assisted Reproductive Technology 4.1.2. In-vitro Fertilization 4.1.3. Intracytoplasmic Sperm Injection 4.1.4. Gamete Donation 4.1.5. Surrogacy 4.1.6. Artificial Insemination 4.1.7. Intrauterine Insemination 4.1.8. Drug Therapy 4.1.9. ART Procedure 4.1.10. Surgical Intervention 4.1.11. Fertility Surgeries 4.1.12. Others 4.2. North America Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 4.2.1. Male Treatment 4.2.2. Female Treatment 4.3. North America Infertility Treatment Market Size and Forecast, by End User (2023-2030) 4.3.1. Fertility Centers 4.3.2. Hospitals & Surgical Clinics 4.3.3. Cryobanks 4.3.4. Research Institutes 4.4. North America Infertility Treatment Market Size and Forecast, by Country (2023-2030) 4.4.1. United States 4.4.1.1. United States Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 4.4.1.1.1. Assisted Reproductive Technology 4.4.1.1.2. In-vitro Fertilization 4.4.1.1.3. Intracytoplasmic Sperm Injection 4.4.1.1.4. Gamete Donation 4.4.1.1.5. Surrogacy 4.4.1.1.6. Artificial Insemination 4.4.1.1.7. Intrauterine Insemination 4.4.1.1.8. Drug Therapy 4.4.1.1.9. ART Procedure 4.4.1.1.10. Surgical Intervention 4.4.1.1.11. Fertility Surgeries 4.4.1.1.12. Others 4.4.1.2. United States Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 4.4.1.2.1. Male Treatment 4.4.1.2.2. Female Treatment 4.4.1.3. United States Infertility Treatment Market Size and Forecast, by End User (2023-2030) 4.4.1.3.1. Fertility Centers 4.4.1.3.2. Hospitals & Surgical Clinics 4.4.1.3.3. Cryobanks 4.4.1.3.4. Research Institutes 4.4.2. Canada 4.4.2.1. Canada Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 4.4.2.1.1. Assisted Reproductive Technology 4.4.2.1.2. In-vitro Fertilization 4.4.2.1.3. Intracytoplasmic Sperm Injection 4.4.2.1.4. Gamete Donation 4.4.2.1.5. Surrogacy 4.4.2.1.6. Artificial Insemination 4.4.2.1.7. Intrauterine Insemination 4.4.2.1.8. Drug Therapy 4.4.2.1.9. ART Procedure 4.4.2.1.10. Surgical Intervention 4.4.2.1.11. Fertility Surgeries 4.4.2.1.12. Others 4.4.2.2. Canada Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 4.4.2.2.1. Male Treatment 4.4.2.2.2. Female Treatment 4.4.2.3. Canada Infertility Treatment Market Size and Forecast, by End User (2023-2030) 4.4.2.3.1. Fertility Centers 4.4.2.3.2. Hospitals & Surgical Clinics 4.4.2.3.3. Cryobanks 4.4.2.3.4. Research Institutes 4.4.3. Mexico 4.4.3.1. Mexico Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 4.4.3.1.1. Assisted Reproductive Technology 4.4.3.1.2. In-vitro Fertilization 4.4.3.1.3. Intracytoplasmic Sperm Injection 4.4.3.1.4. Gamete Donation 4.4.3.1.5. Surrogacy 4.4.3.1.6. Artificial Insemination 4.4.3.1.7. Intrauterine Insemination 4.4.3.1.8. Drug Therapy 4.4.3.1.9. ART Procedure 4.4.3.1.10. Surgical Intervention 4.4.3.1.11. Fertility Surgeries 4.4.3.1.12. Others 4.4.3.2. Mexico Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 4.4.3.2.1. Male Treatment 4.4.3.2.2. Female Treatment 4.4.3.3. Mexico Infertility Treatment Market Size and Forecast, by End User (2023-2030) 4.4.3.3.1. Fertility Centers 4.4.3.3.2. Hospitals & Surgical Clinics 4.4.3.3.3. Cryobanks 4.4.3.3.4. Research Institutes 5. Europe Infertility Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 5.2. Europe Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 5.3. Europe Infertility Treatment Market Size and Forecast, by End User (2023-2030) 5.4. Europe Infertility Treatment Market Size and Forecast, by Country (2023-2030) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 5.4.1.2. United Kingdom Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 5.4.1.3. United Kingdom Infertility Treatment Market Size and Forecast, by End User (2023-2030) 5.4.2. France 5.4.2.1. France Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 5.4.2.2. France Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 5.4.2.3. France Infertility Treatment Market Size and Forecast, by End User (2023-2030) 5.4.3. Germany 5.4.3.1. Germany Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 5.4.3.2. Germany Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 5.4.3.3. Germany Infertility Treatment Market Size and Forecast, by End User (2023-2030) 5.4.4. Italy 5.4.4.1. Italy Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 5.4.4.2. Italy Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 5.4.4.3. Italy Infertility Treatment Market Size and Forecast, by End User (2023-2030) 5.4.5. Spain 5.4.5.1. Spain Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 5.4.5.2. Spain Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 5.4.5.3. Spain Infertility Treatment Market Size and Forecast, by End User (2023-2030) 5.4.6. Sweden 5.4.6.1. Sweden Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 5.4.6.2. Sweden Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 5.4.6.3. Sweden Infertility Treatment Market Size and Forecast, by End User (2023-2030) 5.4.7. Austria 5.4.7.1. Austria Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 5.4.7.2. Austria Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 5.4.7.3. Austria Infertility Treatment Market Size and Forecast, by End User (2023-2030) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 5.4.8.2. Rest of Europe Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 5.4.8.3. Rest of Europe Infertility Treatment Market Size and Forecast, by End User (2023-2030) 6. Asia Pacific Infertility Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 6.2. Asia Pacific Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 6.3. Asia Pacific Infertility Treatment Market Size and Forecast, by End User (2023-2030) 6.4. Asia Pacific Infertility Treatment Market Size and Forecast, by Country (2023-2030) 6.4.1. China 6.4.1.1. China Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 6.4.1.2. China Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 6.4.1.3. China Infertility Treatment Market Size and Forecast, by End User (2023-2030) 6.4.2. S Korea 6.4.2.1. S Korea Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 6.4.2.2. S Korea Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 6.4.2.3. S Korea Infertility Treatment Market Size and Forecast, by End User (2023-2030) 6.4.3. Japan 6.4.3.1. Japan Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 6.4.3.2. Japan Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 6.4.3.3. Japan Infertility Treatment Market Size and Forecast, by End User (2023-2030) 6.4.4. India 6.4.4.1. India Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 6.4.4.2. India Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 6.4.4.3. India Infertility Treatment Market Size and Forecast, by End User (2023-2030) 6.4.5. Australia 6.4.5.1. Australia Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 6.4.5.2. Australia Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 6.4.5.3. Australia Infertility Treatment Market Size and Forecast, by End User (2023-2030) 6.4.6. Indonesia 6.4.6.1. Indonesia Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 6.4.6.2. Indonesia Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 6.4.6.3. Indonesia Infertility Treatment Market Size and Forecast, by End User (2023-2030) 6.4.7. Malaysia 6.4.7.1. Malaysia Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 6.4.7.2. Malaysia Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 6.4.7.3. Malaysia Infertility Treatment Market Size and Forecast, by End User (2023-2030) 6.4.8. Vietnam 6.4.8.1. Vietnam Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 6.4.8.2. Vietnam Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 6.4.8.3. Vietnam Infertility Treatment Market Size and Forecast, by End User (2023-2030) 6.4.9. Taiwan 6.4.9.1. Taiwan Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 6.4.9.2. Taiwan Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 6.4.9.3. Taiwan Infertility Treatment Market Size and Forecast, by End User (2023-2030) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 6.4.10.2. Rest of Asia Pacific Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 6.4.10.3. Rest of Asia Pacific Infertility Treatment Market Size and Forecast, by End User (2023-2030) 7. Middle East and Africa Infertility Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 7.2. Middle East and Africa Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 7.3. Middle East and Africa Infertility Treatment Market Size and Forecast, by End User (2023-2030) 7.4. Middle East and Africa Infertility Treatment Market Size and Forecast, by Country (2023-2030) 7.4.1. South Africa 7.4.1.1. South Africa Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 7.4.1.2. South Africa Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 7.4.1.3. South Africa Infertility Treatment Market Size and Forecast, by End User (2023-2030) 7.4.2. GCC 7.4.2.1. GCC Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 7.4.2.2. GCC Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 7.4.2.3. GCC Infertility Treatment Market Size and Forecast, by End User (2023-2030) 7.4.3. Nigeria 7.4.3.1. Nigeria Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 7.4.3.2. Nigeria Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 7.4.3.3. Nigeria Infertility Treatment Market Size and Forecast, by End User (2023-2030) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 7.4.4.2. Rest of ME&A Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 7.4.4.3. Rest of ME&A Infertility Treatment Market Size and Forecast, by End User (2023-2030) 8. South America Infertility Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 8.2. South America Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 8.3. South America Infertility Treatment Market Size and Forecast, by End User(2023-2030) 8.4. South America Infertility Treatment Market Size and Forecast, by Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 8.4.1.2. Brazil Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 8.4.1.3. Brazil Infertility Treatment Market Size and Forecast, by End User (2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 8.4.2.2. Argentina Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 8.4.2.3. Argentina Infertility Treatment Market Size and Forecast, by End User (2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Infertility Treatment Market Size and Forecast, by Procedure (2023-2030) 8.4.3.2. Rest Of South America Infertility Treatment Market Size and Forecast, by Patient (2023-2030) 8.4.3.3. Rest Of South America Infertility Treatment Market Size and Forecast, by End User (2023-2030) 9. Global Infertility Treatment Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Infertility Treatment Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. CCRM 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Ferring Pharmaceutical 10.3. Merck & Co 10.4. Monash IVF Group 10.5. The Cooper Company 10.6. Thermo Fisher 10.7. United Healthcare Group 10.8. Surelife Pte Ltd. 10.9. Biogenics Inc. 10.10. Cook Group Incorporated 10.11. Esco Micro Pte. Ltd. 10.12. Genea Limited 10.13. Hamilton Throne Ltd. 10.14. Ihmedical A/S 10.15. Invo Bioscience 10.16. Irvine Scientific 10.17. Ivftech APS 10.18. Kitazato 10.19. Labotect GmbH 10.20. Lifeglobal Group LLC 10.21. Medgyn Products Inc. 10.22. Microtech Ivf S.R.O. 10.23. Nikon Instruments Inc. 10.24. Ri.Mos 10.25. Rinovum Women's Health Company 10.26. Rocket Medical PLC 10.27. Somatex Medical Technologies GmbH 10.28. The Baker Company Inc. 10.29. The Cooper Companies Inc. 10.30. Thermo Fisher Scientific Inc. 10.31. Vitrolife AB 10.32. Zander Scientific Inc. 11. Key Findings 12. Industry Recommendations 13. Infertility Treatment Market: Research Methodology 14. Terms and Glossary
